Issue 36: Pharma Digest

Issue 36: Pharma Digest

The Digest is for you, the valued members of our pharma community. Receive the latest market movements, breaking pharma news, business-critical whitepapers and content, and updates on our exclusive executive summits. Don’t forget to subscribe using the button above.

Let's get started.


Using AI for better HCP targeting and education, content creation and data synthesis.??


Over 80% of marketing and medical affairs teams are either already working with AI or actively considering using the technology in the near future, according to Reuters Events' recent survey of 200+ executives, run in conjunction with Elsevier.??Pharma is exploring how AI can be used to support better HCP targeting and education, content creation and data synthesis.?Read the latest whitepaper here.


Reinventing your omnichannel strategy to optimize patient experiences

An effective omnichannel strategy should focus on giving customers what they want, specifically when they want it. Find out how you can reinvent your approach here: https://bit.ly/3zt8XfT A dynamic group of execs from across industry discussed this and more during a recent hackathon, led by Rohit Dayama, Global Client Partner at Cognizant.

#pharmaomnichannel #patientexperience #customerexperience


How pharma can leverage technology to improve patient outcomes??

Our latest PharmaPulse podcast ?? with Gemma Malla Salomó, Business Unit Head at Angelini Pharma. Listen here ?? https://bit.ly/3RHupnq Gemma shares insights on what's needed to accelerate digital health adoption, and how collaboration and ecosystem thinking can drive innovation. Don't miss out on this informative discussion, listen, subscribe and share! #pharmapulse #digitalhealth #pharma #healthcareinnovation


Top 5 pharma news to watch

  1. Pfizer moves forward with once-daily weight-loss pill (Reuters.com, July 11)
  2. Novo Nordisk's Ozempic cuts dementia risk compared with Merck's Januvia: Oxford study (Fierce Pharma, July 12)
  3. China approves CSPC Pharma's RSV vaccine for clinical trials (Reuters.com, July 12)
  4. Amylyx, with GLP-1 buy, doubles down on blood sugar drugs (Biopharma Dive, July 10)
  5. After AdCom rejection, FDA rebuffs Novo Nordisk’s once-weekly insulin (Pharmaceutical Technology, July 11)


Event Spotlight

Join the revolution at the 18th annual Reuters Events: Pharma Japan. As we navigate significant changes in drug approval processes, healthcare provider practices, and patient needs, we are paving the way toward a customer-led model. At this pivotal gathering of industry trailblazers and changemakers, you'll have the opportunity to collaborate, innovate, and influence the future of pharma and healthcare.

Exciting Summer Offer on Pharma Passes!

We're thrilled to announce the release of 40 new passes at an exceptional rate—nearly 50% off last year's prices! Demand is high, and 60+ passes have already been reserved. Don't miss out on this limited-time opportunity. Register now to secure your pass at this unbeatable price.

Other upcoming events

Pharma & Patient USA (October 15-16, Philadelphia)

Pharma Customer Engagement USA (October 22-23, Philadelphia)

Pharma Customer Engagement Europe (November 4-5, London)


That rounds off Issue 36 of the Pharma Digest.

We'll be back in two weeks with more important news, market updates, pharma content, and updates on our events. Don’t forget to subscribe to receive a notification for our next bi-weekly digest.

As always, the Pharma team are on hand to answer your questions. You can connect with us on LinkedIn.


EU Team

Daisy Beale

Karla Sharp

Ziyanda Dludla


USA Team

Kana Hutton

Suzy Wang

Charlotte Bastiaanse

Patrycja Cybinska


Japan Team

Kana Chia


See you next time!


要查看或添加评论,请登录

Reuters Events Pharma的更多文章

社区洞察